Ambulatory intravenous insulin and islet cell transplantation to treat severe type III insulin hypersensitivity in a patient with type 1 diabetes mellitus

Brigette Clarke; Tom Loudovaris; Toni Radford; Chris Drogemuller; Patrick Toby Coates; David Torpy

doi:10.1002/ccr3.3200

Clinical Case Reports (Dec 2020)

Ambulatory intravenous insulin and islet cell transplantation to treat severe type III insulin hypersensitivity in a patient with type 1 diabetes mellitus

Brigette Clarke,
Tom Loudovaris,
Toni Radford,
Chris Drogemuller,
Patrick Toby Coates,
David Torpy

Affiliations

Brigette Clarke: Department of Endocrinology and Metabolism Royal Adelaide Hospital Adelaide SA Australia
Tom Loudovaris: St Vincents Institute Melbourne Vic. Australia
Toni Radford: Central Northern Adelaide Renal and Transplantation Service Royal Adelaide Hospital Adelaide SA Australia
Chris Drogemuller: Faculty of Health and Medical Sciences School of Medicine The University of Adelaide Adelaide SA Australia
Patrick Toby Coates: Faculty of Health and Medical Sciences School of Medicine The University of Adelaide Adelaide SA Australia
David Torpy: Department of Endocrinology and Metabolism Royal Adelaide Hospital Adelaide SA Australia

DOI: https://doi.org/10.1002/ccr3.3200
Journal volume & issue: Vol. 8, no. 12
pp. 2758 – 2761

Abstract

Read online

Abstract Allogenic pancreatic islet cell transplantation is an appropriate treatment option to consider in the management of refractory cases of severe hypersensitivity to insulin in patients with type 1 diabetes mellitus.

Published in Clinical Case Reports

ISSN: 2050-0904 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Medicine (General)
Website: https://onlinelibrary.wiley.com/journal/20500904

About the journal

Abstract

Keywords